Skip to main content
. 2017 May 5;8(37):60962–60974. doi: 10.18632/oncotarget.17631

Figure 6. CAT-1 siRNA inhibits the tumorigenic effects of HBx in HepG2/HepG2. 2.15 cells.

Figure 6

(A) Cell proliferation of HepG2 transfected with pHBx, pHBx with psiCAT-1, HepG2.2.15 transfected with psiCAT-1 as-detected by MTT assay. (B, C) Clone efficiency of HepG2 transfected with pCDNA, pHBx, pHBx with psi-NC, pHBx with psi-HBx, pHBx with psi-CAT-1 as-assessed by cell colony formation assay. Statistically significant differences are indicated: *p<0.05, ***p<0.001, ****p<0.0001. Data represent mean ± SD. Experiments were performed in triplicate.